IL-36 receptor drugs for Psoriasis
4 tracked IL-36 receptor drugs in the Psoriasis race. The class explanation lives on the IL-36 receptor page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 41 Phase 31 Phase 2/31 Phase 2
Head-to-head evidence: HB0034 vs Imsidolimab · HB0034 vs SHR-1139 · HB0034 vs spesolimab · Imsidolimab vs SHR-1139 · Imsidolimab vs spesolimab · SHR-1139 vs spesolimab